Insider Transactions Reported by 5 Insiders of Biodexa Pharmaceuticals Plc

Symbol
BDRX on Nasdaq
Location
Cardiff

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Biodexa Pharmaceuticals Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Simon Turton Director $2,377 18 Mar 2026
Fiona Mary Powell Chief Financial Officer, Director 18 Mar 2026
Simon de Vries Director 18 Mar 2026
Stephen Anthony Stamp Chief Executive Officer, Director 18 Mar 2026
Ann Louise Merchant Director 18 Mar 2026

Recent Insider Transactions by Companies or Individuals for Biodexa Pharmaceuticals Plc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Simon Turton BDRX Ordinary Shares 0 2,765 18 Mar 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.